UK markets closed

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
170.81-5.12 (-2.91%)
As of 01:29PM EST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 70.06B
Enterprise value 62.97B
Trailing P/E 6.57
Forward P/E 28.33
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.72
Price/book (mrq)3.89
Enterprise value/revenue 3.05
Enterprise value/EBITDA 4.60

Trading information

Stock price history

Beta (5Y monthly) 1.73
52-week change 3-37.69%
S&P500 52-week change 3-14.68%
52-week high 3321.30
52-week low 3115.03
50-day moving average 3149.82
200-day moving average 3150.02

Share statistics

Avg vol (3-month) 34.74M
Avg vol (10-day) 33.14M
Shares outstanding 5384.18M
Implied shares outstanding 6N/A
Float 8346.79M
% held by insiders 19.70%
% held by institutions 165.82%
Shares short (14 Nov 2022) 415.98M
Short ratio (14 Nov 2022) 43.07
Short % of float (14 Nov 2022) 45.64%
Short % of shares outstanding (14 Nov 2022) 44.16%
Shares short (prior month 13 Oct 2022) 416.16M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin 55.00%
Operating margin (ttm)61.94%

Management effectiveness

Return on assets (ttm)35.25%
Return on equity (ttm)83.69%

Income statement

Revenue (ttm)21.39B
Revenue per share (ttm)53.68
Quarterly revenue growth (yoy)-32.30%
Gross profit (ttm)13.86B
EBITDA 13.6B
Net income avi to common (ttm)11.77B
Diluted EPS (ttm)28.20
Quarterly earnings growth (yoy)-68.70%

Balance sheet

Total cash (mrq)8.35B
Total cash per share (mrq)21.73
Total debt (mrq)1.26B
Total debt/equity (mrq)7.01
Current ratio (mrq)2.10
Book value per share (mrq)46.49

Cash flow statement

Operating cash flow (ttm)6.63B
Levered free cash flow (ttm)3.78B